BioCentury | Oct 27, 2020
Product Development
Oct. 26 Quick Takes: COVID trips up Spectrum’s Rolontis at FDA; plus Jazz-SpringWorks, Novartis’ iptacopan, Kantaro, Eternygen
...Fatty acid amid hydrolase
BC Staff
LAPS-GCSF, Rolontis, eflapegrastim (HM10460A, SPI-2012)
LNP023
Spectrum Pharmaceuticals Inc.
Jazz Pharmaceuticals plc
SpringWorks Therapeutics Inc.
Novartis AG
Kantaro Biosciences LLC
Eternygen...
